Post Marketing Surveillance of Nintedanib in Indian Patients With Non-small Cell Lung Cancer (NSCLC) After First-line Therapy
Clinical trial NCT03017885 · COMPLETED
Trial details
- NCT number
- NCT03017885
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-02-28
- Primary completion
- 2022-09-24
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.